Kyverna Therapeutics (KYTX) Non Operating Income (2023 - 2026)
Kyverna Therapeutics' Non Operating Income was $1.24 million in Q2 2026, down 46.9% from $2.33 million a year earlier and down 24.5% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Non Operating Income (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Kyverna Therapeutics' Non Operating Income was $6.29 million through Jun 30, 2026, down 51.3% year-over-year; for FY2025, it came in at $8.52 million, down 43.7% from FY2024.
- In earlier years, Non Operating Income was $15.13 million in FY2024 (+641.5%) and $2.04 million in FY2023.
- The Q2 2026 figure marks the lowest quarterly Non Operating Income since Q4 2023.
- Compared with a year earlier, Non Operating Income has declined for five straight quarters, with growth averaging 72.2% over the last eight quarters.
- The best year-over-year quarter for Non Operating Income over five years was Q1 2024 (growth of 782.5%); the worst was Q4 2025 (a decline of 58.4%).
- Per Business Quant data, KYTX's Non Operating Income in the three quarters before Q2 2026 was $1.64 million (Q1 2026), $1.48 million (Q4 2025) and $1.94 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Kyverna Therapeutics | 312.78 Mn | -573.60 Mn | - | 1.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.48 Mn |
| Sep 30, 2025 | 1.94 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 2.77 Mn |
| Dec 31, 2024 | 3.55 Mn |
| Sep 30, 2024 | 4.28 Mn |
| Jun 30, 2024 | 4.63 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 710,000.00 |
| Sep 30, 2023 | 817,000.00 |
| Jun 30, 2023 | 211,000.00 |
| Mar 31, 2023 | 302,000.00 |
API Access
Kyverna Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();